SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-101611
Filing Date
2023-09-18
Accepted
2023-09-18 16:30:45
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 tm2323585-5_s3.htm S-3 429288
2 EXHIBIT 1.2 tm2323585d6_ex1-2.htm EX-1.2 229958
3 EXHIBIT 5.1 tm2323585d6_ex5-1.htm EX-5.1 24977
4 EXHIBIT 23.2 tm2323585d6_ex23-2.htm EX-23.2 2622
5 EX-FILING FEES tm2323585d6_ex-filingfees.htm EX-FILING FEES 18841
6 GRAPHIC lg_ampiopharma-4c.jpg GRAPHIC 20200
7 GRAPHIC tm2323585d6_ex5-1img01.jpg GRAPHIC 2121
  Complete submission text file 0001104659-23-101611.txt   737815
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274558 | Film No.: 231261540
SIC: 2834 Pharmaceutical Preparations